米国企業
TG THERAPEUTICS, INC.

TG THERAPEUTICS, INC.TGTX

時価総額

$25.4億

PER

200.8倍

	2013年 12月31日	2014年 12月31日	2015年 12月31日	2016年 12月31日	2017年 12月31日	2018年 12月31日	2019年 12月31日	2020年 12月31日	2021年 12月31日	2022年 12月31日	2023年 12月31日
Product	-	-	-	-	-	-	-	-	7	3	92
License	-	-	-	-	-	-	-	-	0	0	142
Product	-	-	-	-	-	-	-	-	7	3	92
License	-	-	-	-	-	-	-	-	0	0	142
Product	-	-	-	-	-	-	-	-	7	3	92
License	-	-	-	-	-	-	-	-	0	0	142
Revenue	-	-	-	-	-	0	0	0	7	3	234
Product	-	-	-	-	-	-	-	-	7	3	92
License	-	-	-	-	-	-	-	-	0	0	142
Product	-	-	-	-	-	-	-	-	7	3	92
License	-	-	-	-	-	-	-	-	0	0	142
Product	-	-	-	-	-	-	-	-	7	3	92
License	-	-	-	-	-	-	-	-	0	0	142
Revenue	-	-	-	-	-	0	0	0	7	3	234
Cost of revenue	-	-	-	-	-	-	-	-	-	-	14
Cost of product revenue	-	-	-	-	-	-	-	-	1	0	-
Noncash compensation	1	9	4	3	6	6	6	14	24	13	13
Noncash compensation	1	9	4	3	6	6	6	14	24	13	13
Other research and development	17	26	43	66	97	150	148	152	199	112	63
Other research and development	17	26	43	66	97	150	148	152	199	112	63
Total research and development	35	40	48	69	103	159	154	166	223	125	76
Total research and development	35	40	48	69	103	159	154	166	223	125	76
Noncash compensation	-	-	-	-	-	-	-	-	37	6	25
Noncash compensation	-	-	-	-	-	-	-	-	37	6	25
Other selling, general and administrative	-	-	-	-	-	-	-	-	91	64	98
Other selling, general and administrative	-	-	-	-	-	-	-	-	91	64	98
Total selling, general and administrative	-	-	-	-	-	-	-	-	128	70	123
Total selling, general and administrative	-	-	-	-	-	-	-	-	128	70	123
Total costs and expenses	-	-	-	-	-	-	-	-	-	-	213
Operating income (loss)	-22,965,989	-55,721,092	-63,180,016	-78,969,128	-118,711,751	-174	-169	-274	-345	-193	21
Total costs and expenses	51	56	63	79	119	175	169	274	351	196	213
Operating income (loss)	-22,965,989	-55,721,092	-63,180,016	-78,969,128	-118,711,751	-174	-169	-274	-345	-193	21
Cost of revenue	-	-	-	-	-	-	-	-	-	-	14
Cost of product revenue	-	-	-	-	-	-	-	-	1	0	-
Noncash compensation	1	9	4	3	6	6	6	14	24	13	13
Noncash compensation	1	9	4	3	6	6	6	14	24	13	13
Other research and development	17	26	43	66	97	150	148	152	199	112	63
Other research and development	17	26	43	66	97	150	148	152	199	112	63
Total research and development	35	40	48	69	103	159	154	166	223	125	76
Total research and development	35	40	48	69	103	159	154	166	223	125	76
Noncash compensation	-	-	-	-	-	-	-	-	37	6	25
Noncash compensation	-	-	-	-	-	-	-	-	37	6	25
Other selling, general and administrative	-	-	-	-	-	-	-	-	91	64	98
Other selling, general and administrative	-	-	-	-	-	-	-	-	91	64	98
Total selling, general and administrative	-	-	-	-	-	-	-	-	128	70	123
Total selling, general and administrative	-	-	-	-	-	-	-	-	128	70	123
Total costs and expenses	-	-	-	-	-	-	-	-	-	-	213
Operating income (loss)	-22,965,989	-55,721,092	-63,180,016	-78,969,128	-118,711,751	-174	-169	-274	-345	-193	21
Total costs and expenses	51	56	63	79	119	175	169	274	351	196	213
Operating income (loss)	-22,965,989	-55,721,092	-63,180,016	-78,969,128	-118,711,751	-174	-169	-274	-345	-193	21
Noncash compensation	1	9	4	3	6	6	6	14	24	13	13
Noncash compensation	1	9	4	3	6	6	6	14	24	13	13
Other research and development	17	26	43	66	97	150	148	152	199	112	63
Other research and development	17	26	43	66	97	150	148	152	199	112	63
Total research and development	35	40	48	69	103	159	154	166	223	125	76
Total research and development	35	40	48	69	103	159	154	166	223	125	76
Interest expense	2	930,701	972,736	-	-	-	5	6	6	10	13
Interest expense	2	930,701	972,736	-	-	-	5	6	6	10	13
Other income	-	-	-	-	-	-	-	-	-	-	5
Other income	381,126	95,427	-	393,202	-58,739	0	1	1	2	5	-
Total other expense (income), net	4	-60,185	231,370	716,234	235,739	1	-4	-6	-3	-5	-8
Total other expense (income), net	4	-60,185	231,370	716,234	235,739	1	-4	-6	-3	-5	-8
Net income (loss) before taxes	-20,478,210	-	-	-	-	-	-	-	-	-	13
Net loss	-20,478,210	-55,781,277	-62,948,646	-78,252,894	-118,476,012	-173	-173	-279	-348	-198	-
Income taxes	330,000	-	-	-	-	-	-	-	-	-	0
Basic (in dollars per share)	-	-	-	-	-	-	-	-	-	-1.46	0.09
Net income (loss)	-20,478,210	-55,781,277	-62,948,646	-78,252,894	-118,476,012	-173	-173	-279	-348	-198	13
Diluted (in dollars per share)	-	-	-	-	-	-	-	-	-	-1.46	0.09
Noncash compensation	-	-	-	-	-	-	-	-	37	6	25
Noncash compensation	-	-	-	-	-	-	-	-	37	6	25
Other selling, general and administrative	-	-	-	-	-	-	-	-	91	64	98
Other selling, general and administrative	-	-	-	-	-	-	-	-	91	64	98
Total selling, general and administrative	-	-	-	-	-	-	-	-	128	70	123
Total selling, general and administrative	-	-	-	-	-	-	-	-	128	70	123
Total costs and expenses	-	-	-	-	-	-	-	-	-	-	213
Operating income (loss)	-22,965,989	-55,721,092	-63,180,016	-78,969,128	-118,711,751	-174	-169	-274	-345	-193	21
Interest expense	2	930,701	972,736	-	-	-	5	6	6	10	13
Interest expense	2	930,701	972,736	-	-	-	5	6	6	10	13
Other income	-	-	-	-	-	-	-	-	-	-	5
Other income	381,126	95,427	-	393,202	-58,739	0	1	1	2	5	-
Total other expense (income), net	4	-60,185	231,370	716,234	235,739	1	-4	-6	-3	-5	-8
Total other expense (income), net	4	-60,185	231,370	716,234	235,739	1	-4	-6	-3	-5	-8
Net income (loss) before taxes	-20,478,210	-	-	-	-	-	-	-	-	-	13
Net loss	-20,478,210	-55,781,277	-62,948,646	-78,252,894	-118,476,012	-173	-173	-279	-348	-198	-
Income taxes	330,000	-	-	-	-	-	-	-	-	-	0
Basic (in dollars per share)	-	-	-	-	-	-	-	-	-	-1.46	0.09
Net income (loss)	-20,478,210	-55,781,277	-62,948,646	-78,252,894	-118,476,012	-173	-173	-279	-348	-198	13
Diluted (in dollars per share)	-	-	-	-	-	-	-	-	-	-1.46	0.09
Basic (in dollars per share)	-	-	-	-	-	-	-	-	-	-1.46	0.09
Diluted (in dollars per share)	-	-	-	-	-	-	-	-	-	-1.46	0.09
Product	-	-	-	-	-	-	-	-	7	3	92
License	-	-	-	-	-	-	-	-	0	0	142
Product	-	-	-	-	-	-	-	-	7	3	92
License	-	-	-	-	-	-	-	-	0	0	142
Product	-	-	-	-	-	-	-	-	7	3	92
License	-	-	-	-	-	-	-	-	0	0	142
Revenue	-	-	-	-	-	0	0	0	7	3	234
Product	-	-	-	-	-	-	-	-	7	3	92
License	-	-	-	-	-	-	-	-	0	0	142
Product	-	-	-	-	-	-	-	-	7	3	92
License	-	-	-	-	-	-	-	-	0	0	142
Product	-	-	-	-	-	-	-	-	7	3	92
License	-	-	-	-	-	-	-	-	0	0	142
Revenue	-	-	-	-	-	0	0	0	7	3	234
Cost of revenue	-	-	-	-	-	-	-	-	-	-	14
Cost of product revenue	-	-	-	-	-	-	-	-	1	0	-
Noncash compensation	1	9	4	3	6	6	6	14	24	13	13
Noncash compensation	1	9	4	3	6	6	6	14	24	13	13
Other research and development	17	26	43	66	97	150	148	152	199	112	63
Other research and development	17	26	43	66	97	150	148	152	199	112	63
Total research and development	35	40	48	69	103	159	154	166	223	125	76
Total research and development	35	40	48	69	103	159	154	166	223	125	76
Noncash compensation	-	-	-	-	-	-	-	-	37	6	25
Noncash compensation	-	-	-	-	-	-	-	-	37	6	25
Other selling, general and administrative	-	-	-	-	-	-	-	-	91	64	98
Other selling, general and administrative	-	-	-	-	-	-	-	-	91	64	98
Total selling, general and administrative	-	-	-	-	-	-	-	-	128	70	123
Total selling, general and administrative	-	-	-	-	-	-	-	-	128	70	123
Total costs and expenses	-	-	-	-	-	-	-	-	-	-	213
Operating income (loss)	-22,965,989	-55,721,092	-63,180,016	-78,969,128	-118,711,751	-174	-169	-274	-345	-193	21
Total costs and expenses	51	56	63	79	119	175	169	274	351	196	213
Operating income (loss)	-22,965,989	-55,721,092	-63,180,016	-78,969,128	-118,711,751	-174	-169	-274	-345	-193	21
Cost of revenue	-	-	-	-	-	-	-	-	-	-	14
Cost of product revenue	-	-	-	-	-	-	-	-	1	0	-
Noncash compensation	1	9	4	3	6	6	6	14	24	13	13
Noncash compensation	1	9	4	3	6	6	6	14	24	13	13
Other research and development	17	26	43	66	97	150	148	152	199	112	63
Other research and development	17	26	43	66	97	150	148	152	199	112	63
Total research and development	35	40	48	69	103	159	154	166	223	125	76
Total research and development	35	40	48	69	103	159	154	166	223	125	76
Noncash compensation	-	-	-	-	-	-	-	-	37	6	25
Noncash compensation	-	-	-	-	-	-	-	-	37	6	25
Other selling, general and administrative	-	-	-	-	-	-	-	-	91	64	98
Other selling, general and administrative	-	-	-	-	-	-	-	-	91	64	98
Total selling, general and administrative	-	-	-	-	-	-	-	-	128	70	123
Total selling, general and administrative	-	-	-	-	-	-	-	-	128	70	123
Total costs and expenses	-	-	-	-	-	-	-	-	-	-	213
Operating income (loss)	-22,965,989	-55,721,092	-63,180,016	-78,969,128	-118,711,751	-174	-169	-274	-345	-193	21
Total costs and expenses	51	56	63	79	119	175	169	274	351	196	213
Operating income (loss)	-22,965,989	-55,721,092	-63,180,016	-78,969,128	-118,711,751	-174	-169	-274	-345	-193	21
Noncash compensation	1	9	4	3	6	6	6	14	24	13	13
Noncash compensation	1	9	4	3	6	6	6	14	24	13	13
Other research and development	17	26	43	66	97	150	148	152	199	112	63
Other research and development	17	26	43	66	97	150	148	152	199	112	63
Total research and development	35	40	48	69	103	159	154	166	223	125	76
Total research and development	35	40	48	69	103	159	154	166	223	125	76
Interest expense	2	930,701	972,736	-	-	-	5	6	6	10	13
Interest expense	2	930,701	972,736	-	-	-	5	6	6	10	13
Other income	-	-	-	-	-	-	-	-	-	-	5
Other income	381,126	95,427	-	393,202	-58,739	0	1	1	2	5	-
Total other expense (income), net	4	-60,185	231,370	716,234	235,739	1	-4	-6	-3	-5	-8
Total other expense (income), net	4	-60,185	231,370	716,234	235,739	1	-4	-6	-3	-5	-8
Net income (loss) before taxes	-20,478,210	-	-	-	-	-	-	-	-	-	13
Net loss	-20,478,210	-55,781,277	-62,948,646	-78,252,894	-118,476,012	-173	-173	-279	-348	-198	-
Income taxes	330,000	-	-	-	-	-	-	-	-	-	0
Basic (in dollars per share)	-	-	-	-	-	-	-	-	-	-1.46	0.09
Net income (loss)	-20,478,210	-55,781,277	-62,948,646	-78,252,894	-118,476,012	-173	-173	-279	-348	-198	13
Diluted (in dollars per share)	-	-	-	-	-	-	-	-	-	-1.46	0.09
Noncash compensation	-	-	-	-	-	-	-	-	37	6	25
Noncash compensation	-	-	-	-	-	-	-	-	37	6	25
Other selling, general and administrative	-	-	-	-	-	-	-	-	91	64	98
Other selling, general and administrative	-	-	-	-	-	-	-	-	91	64	98
Total selling, general and administrative	-	-	-	-	-	-	-	-	128	70	123
Total selling, general and administrative	-	-	-	-	-	-	-	-	128	70	123
Total costs and expenses	-	-	-	-	-	-	-	-	-	-	213
Operating income (loss)	-22,965,989	-55,721,092	-63,180,016	-78,969,128	-118,711,751	-174	-169	-274	-345	-193	21
Interest expense	2	930,701	972,736	-	-	-	5	6	6	10	13
Interest expense	2	930,701	972,736	-	-	-	5	6	6	10	13
Other income	-	-	-	-	-	-	-	-	-	-	5
Other income	381,126	95,427	-	393,202	-58,739	0	1	1	2	5	-
Total other expense (income), net	4	-60,185	231,370	716,234	235,739	1	-4	-6	-3	-5	-8
Total other expense (income), net	4	-60,185	231,370	716,234	235,739	1	-4	-6	-3	-5	-8
Net income (loss) before taxes	-20,478,210	-	-	-	-	-	-	-	-	-	13
Net loss	-20,478,210	-55,781,277	-62,948,646	-78,252,894	-118,476,012	-173	-173	-279	-348	-198	-
Income taxes	330,000	-	-	-	-	-	-	-	-	-	0
Basic (in dollars per share)	-	-	-	-	-	-	-	-	-	-1.46	0.09
Net income (loss)	-20,478,210	-55,781,277	-62,948,646	-78,252,894	-118,476,012	-173	-173	-279	-348	-198	13
Diluted (in dollars per share)	-	-	-	-	-	-	-	-	-	-1.46	0.09
Basic (in dollars per share)	-	-	-	-	-	-	-	-	-	-1.46	0.09
Diluted (in dollars per share)	-	-	-	-	-	-	-	-	-	-1.46	0.09